Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXG8L0
|
||||
| Drug Name |
6-(4-chlorobenzyl)-7-(2-cyclohexylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile
|
||||
| Synonyms |
CHEMBL524045
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H23ClN4
|
||||
| Canonical SMILES |
Clc1ccc(Cc2cc3cnc(nc3n2CCC4CCCCC4)C#N)cc1
|
||||
| InChI |
InChI=1S/C22H23ClN4/c23-19-8-6-17(7-9-19)12-20-13-18-15-25-21(14-24)26-22(18)27(20)11-10-16-4-2-1-3-5-16/h6-9,13,15-16H,1-5,10-12H2
|
||||
| InChIKey |
FTEBHYTXXKJNBZ-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.